Area of research
Cancer Research · Surgery
Research interest
Research focused on Cancer research and Downregulation and upregulation, with related work in Long non-coding RNA, RNA, PI3K/AKT/mTOR pathway. Notable publications include 'SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma', 'Lnc RNA ‐ ATB : An indispensable cancer‐related long noncoding RNA', and 'Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells'.
Research progress and applications of epigenetic biomarkers in cancer
Utilization of 3D printing technology in hepatopancreatobiliary surgery
Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review
Clathrin light chain A‐enriched small extracellular vesicles remodel microvascular niche to induce hepatocellular carcinoma metastasis
Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression
Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy
Exosomal miRNAs in the microenvironment of pancreatic cancer
Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer
Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma
Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment
Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
Reprogramming of central carbon metabolism in hepatocellular carcinoma
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2
Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
Prevention of distal stent graft-induced new entry after endovascular repair for type B aortic dissection: A retrospective cohort study
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment
Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer
G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy
Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value
Circular RNA circ_ABCB10 in cancer
The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma
LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors